Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Orr

Showing results (31-40 of 363) with videos related to

Pageof 37
Sort By:
Medical Care|June 1, 1981
Utilization of health services by poor children since advent of medicaidS T Orr, C A Miller
Annual Review of Neuroscience|June 9, 2000
Glutamine repeats and neurodegenerationH Y Zoghbi, H T Orr
Critical Reviews in Immunology|January 1, 1993
Maternal/fetal interactions: the role of the MHC class I molecule HLA-GC M Schmidt, H T Orr
The Journal of Biological Chemistry|October 30, 2008
Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1Huda Y Zoghbi, Harry T Orr
Neuron|August 19, 2007
Fragile X tremor/ataxia syndrome: blame the messenger!Maurice S Swanson, Harry T Orr
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 2, 2016
Diminishing return for mechanistic therapeutics with neurodegenerative disease duration?: There may be a point in the course of a neurodegenerative condition where therapeutics targeting disease-causing mechanisms are futileDavid C Rubinsztein, Harry T Orr
Neuron|October 20, 2023
HD and SCA1: Tales from two 30-year journeys since gene discoveryLeslie M Thompson, Harry T Orr
Human Immunology|October 1, 1990
Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissueX H Wei, H T Orr
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1989
Regulation of HLA class I transcription in T cellsK R Zachow, H T Orr
Cell|December 6, 2001
RNA targets of the fragile X proteinM D Kaytor, H T Orr
Pageof 37

Showing results (31-40 of 363) with videos related to

Sort By:
Pageof 37
Medical Care|June 1, 1981
Utilization of health services by poor children since advent of medicaidS T Orr, C A Miller
Annual Review of Neuroscience|June 9, 2000
Glutamine repeats and neurodegenerationH Y Zoghbi, H T Orr
Critical Reviews in Immunology|January 1, 1993
Maternal/fetal interactions: the role of the MHC class I molecule HLA-GC M Schmidt, H T Orr
The Journal of Biological Chemistry|October 30, 2008
Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1Huda Y Zoghbi, Harry T Orr
Neuron|August 19, 2007
Fragile X tremor/ataxia syndrome: blame the messenger!Maurice S Swanson, Harry T Orr
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 2, 2016
Diminishing return for mechanistic therapeutics with neurodegenerative disease duration?: There may be a point in the course of a neurodegenerative condition where therapeutics targeting disease-causing mechanisms are futileDavid C Rubinsztein, Harry T Orr
Neuron|October 20, 2023
HD and SCA1: Tales from two 30-year journeys since gene discoveryLeslie M Thompson, Harry T Orr
Human Immunology|October 1, 1990
Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissueX H Wei, H T Orr
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1989
Regulation of HLA class I transcription in T cellsK R Zachow, H T Orr
Cell|December 6, 2001
RNA targets of the fragile X proteinM D Kaytor, H T Orr
Pageof 37